Utama › Keadaan Pasca-COVID (Long COVID) › Michigan
Kajian klinikal Keadaan Pasca-COVID (Long COVID) di Michigan
6 kajian untuk Keadaan Pasca-COVID (Long COVID) sedang mencari peserta di lokasi di Michigan.
Bandar di Michigan
Teks kajian rasmi (Bahasa Inggeris)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Henry Ford St John TM Center for Infectious Disease Research ( Site 3766), Grosse Pointe Woods
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06667700Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Detroit
- Research Site, Royal Oak
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- University of Michigan, Ann Arbor
- Henry Ford Hospital, Detroit
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Revival Research Institute, LLC, Dearborn
- Henry Ford St. John Hospital, Grosse Pointe Woods
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140Predictors of Post-COVID-19 Clinical and Cognitive Consequences
- John D. Dingell VA Medical Center, Detroit, MI, Detroit
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jan 2026 · NCT06291870Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- University of Michigan, Ann Arbor
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jul 2024 · NCT02735707Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.